These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 3984310)
21. A new monoclonal antibody (A78-G/A7) to the Thomsen-Friedenreich pan-tumor antigen. Karsten U; Butschak G; Cao Y; Goletz S; Hanisch FG Hybridoma; 1995 Feb; 14(1):37-44. PubMed ID: 7539400 [TBL] [Abstract][Full Text] [Related]
22. The human repertoire of antibody specificities against Thomsen-Friedenreich and Tn-carcinoma-associated antigens as defined by human monoclonal antibodies. Jansson B; Borrebaeck CA Cancer Immunol Immunother; 1992; 34(5):294-8. PubMed ID: 1540975 [TBL] [Abstract][Full Text] [Related]
23. Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin. Campbell BJ; Finnie IA; Hounsell EF; Rhodes JM J Clin Invest; 1995 Feb; 95(2):571-6. PubMed ID: 7860740 [TBL] [Abstract][Full Text] [Related]
24. Anti-Thomsen-Friedenreich-Ag (anti-TF-Ag) potential for cancer therapy. Almogren A; Abdullah J; Ghapure K; Ferguson K; Glinsky VV; Rittenhouse-Olson K Front Biosci (Schol Ed); 2012 Jan; 4(3):840-63. PubMed ID: 22202095 [TBL] [Abstract][Full Text] [Related]
25. Properties of cold agglutinin and group carbohydrate-specific antibodies isolated from group C streptococcal antisera. Brown JC; Colling RG Mol Immunol; 1982 Mar; 19(3):457-65. PubMed ID: 7099171 [TBL] [Abstract][Full Text] [Related]
26. Specificity of reagents directed to the Thomsen-Friedenreich antigen and their capacity to bind to the surface of human carcinoma cell lines. Wolf MF; Koerner U; Schumacher K Cancer Res; 1986 Apr; 46(4 Pt 1):1779-82. PubMed ID: 2418954 [TBL] [Abstract][Full Text] [Related]
27. Enzymatic syntheses of T antigen-containing glycolipid mimicry using the transglycosylation activity of endo-alpha-N-acetylgalactosaminidase. Ashida H; Yamamoto K; Kumagai H Carbohydr Res; 2001 Feb; 330(4):487-93. PubMed ID: 11269400 [TBL] [Abstract][Full Text] [Related]
28. Isolation, characterization and implications of anti-TF (Thomsen-Friedenreich) agglutinins from different sources. Kania J; Uhlenbruck G; Janssen E; Klein PJ; Vierbuchen M Immunobiology; 1980 Jul; 157(2):154-68. PubMed ID: 6157637 [TBL] [Abstract][Full Text] [Related]
29. Immunological evaluation of the entirely carbohydrate-based Thomsen-Friedenreich - PS B conjugate. Trabbic KR; Bourgault JP; Shi M; Clark M; Andreana PR Org Biomol Chem; 2016 Apr; 14(13):3350-5. PubMed ID: 26958987 [TBL] [Abstract][Full Text] [Related]
30. Analysis of human tumor associated Thomsen-Friedenreich antigen. Samuel J; Noujaim AA; MacLean GD; Suresh MR; Longenecker BM Cancer Res; 1990 Aug; 50(15):4801-8. PubMed ID: 2196117 [TBL] [Abstract][Full Text] [Related]
31. Binding studies on the combining site of a GalNAc alpha 1-->-specific lectin with Thomsen-Friedenreich activity prepared from green marine algae Codium fragile subspecies tomentosoides. Wu AM; Song SC; Hwang PY; Wu JH; Chang KS Eur J Biochem; 1995 Oct; 233(1):145-51. PubMed ID: 7588738 [TBL] [Abstract][Full Text] [Related]
32. Signatures of anti-ThomsenĀ - Friedenreich antigen antibody diversity in colon cancer patients. Kurtenkov O; Bubina M; Klaamas K Exp Oncol; 2018 Mar; 40(1):48-58. PubMed ID: 29600973 [TBL] [Abstract][Full Text] [Related]
33. Human monoclonal antibodies specific for the tumour associated Thomsen-Friedenreich antigen. Dahlenborg K; Hultman L; Carlsson R; Jansson B Int J Cancer; 1997 Jan; 70(1):63-71. PubMed ID: 8985092 [TBL] [Abstract][Full Text] [Related]
34. Use of a synthetic hapten in the demonstration of the Thomsen-Friedenreich (T) antigen on neuraminidase-treated human red blood cells and lymphocytes. Bray J; Lemieux RU; McPherson TA J Immunol; 1981 May; 126(5):1966-9. PubMed ID: 7217675 [TBL] [Abstract][Full Text] [Related]
35. Enhanced Immune Response Against the Thomsen-Friedenreich Tumor Antigen Using a Bivalent Entirely Carbohydrate Conjugate. Kleski KA; Trabbic KR; Shi M; Bourgault JP; Andreana PR Molecules; 2020 Mar; 25(6):. PubMed ID: 32183149 [TBL] [Abstract][Full Text] [Related]
36. Binding of galectin-1 (gal-1) to the Thomsen-Friedenreich (TF) antigen on trophoblast cells and inhibition of proliferation of trophoblast tumor cells in vitro by gal-1 or an anti-TF antibody. Jeschke U; Karsten U; Wiest I; Schulze S; Kuhn C; Friese K; Walzel H Histochem Cell Biol; 2006 Oct; 126(4):437-44. PubMed ID: 16607538 [TBL] [Abstract][Full Text] [Related]
37. Clinical significance of the Thomsen-Friedenreich antigen. MacLean GD; Longenecker BM Semin Cancer Biol; 1991 Dec; 2(6):433-9. PubMed ID: 1810470 [TBL] [Abstract][Full Text] [Related]
38. Preparation and characterization of monoclonal antibodies to an N-linked oligosaccharide. Masutani S; Miyazawa N; Fujii S; Nishikawa A; Matsukawa H; Shimano T; Mori T; Taniguchi N Anal Biochem; 1990 Jul; 188(1):149-54. PubMed ID: 2221355 [TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibody BW835 defines a site-specific Thomsen-Friedenreich disaccharide linked to threonine within the VTSA motif of MUC1 tandem repeats. Hanisch FG; Stadie T; Bosslet K Cancer Res; 1995 Sep; 55(18):4036-40. PubMed ID: 7545084 [TBL] [Abstract][Full Text] [Related]
40. Expression of Thomsen-Friedenreich (TF) antigens on lymphocytes. I. Distribution of cryptic and exposed TF antigens on murine lymphocytes from different lymphoid organs: detection with an anti-TF monoclonal antibody and peanut agglutinin. Wolf MF; Schmitt HR; Schumacher K Cell Immunol; 1989 Jul; 121(2):360-5. PubMed ID: 2736629 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]